Oyster Point Pharma, Inc.

Informe acción NasdaqGS:OYST

Capitalización de mercado: US$303.2m

Salud financiera de hoja de balance de Oyster Point Pharma

Salud financiera controles de criterios 0/6

Información clave

-415.4%

Ratio deuda-patrimonio

US$92.22m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$68.80m
Patrimonio-US$22.20m
Total pasivoUS$131.40m
Activos totalesUS$109.20m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Nov 08
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Oyster Point's nasal spray to be covered by largest Medicare pharmacy benefit manager

Aug 17

Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 14
Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Oyster Point stock rises 11% after H.C. Wainwright begins coverage with Buy rating

Jul 18

Oyster Therapeutics: State Of Business Is Confounding

Jun 30

Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Dec 24
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?

Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans

Oct 15
Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans

Oyster Point Pharma starts enrollment in mid-stage Neurotrophic Keratopathy study

Jun 21

Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation

Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares

Feb 09
Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares

Oyster Point Pharma files US application for its lead program in dry eye disease

Dec 18

Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth

Dec 18
Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth

Oyster Point Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 06

Análisis de la situación financiera

Pasivos a corto plazo: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Pasivo a largo plazo: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: OYST has negative shareholder equity, which is a more serious situation than a high debt level.

Reducción de la deuda: OYST's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: OYST has less than a year of cash runway based on its current free cash flow.

Pronóstico de cash runway: OYST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 49.1% each year


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target